Revised Understanding of Sepsis Incidence: A Norwegian Study

by Henrik Andersen
7 comments
sepsis treatment

A thorough research effort originating from Norway has revealed a higher incidence of sepsis than previously documented. Specifically, 250 out of every 100,000 individuals in Norway are afflicted with sepsis each year. The study dismantles prior assumptions about reporting increases, highlights a significant reduction in mortality rates associated with sepsis in hospitals, and underlines the uptick in recurrent sepsis, particularly among the aging population.

The primary factor contributing to the increasing number of sepsis cases is recurrent episodes of the condition, rather than fatalities upon initial onset.

Though colloquially referred to as blood poisoning, sepsis is a critical medical situation that leads to the death of about 3,000 people each year in Norwegian medical facilities. The condition is not a form of poisoning per se, but occurs due to an exaggerated immune response to an infection, which could be bacterial, viral, fungal, or parasitic. This overreactive immune response results in damage to the organs, culminating in organ failure.

The investigation, which analyzed 300,000 sepsis hospital admissions, found that the condition is more widespread than once believed. Moreover, an increased survival rate was noted, largely due to patients experiencing multiple episodes of sepsis rather than succumbing to the condition upon its first occurrence.

According to Lise Tuset Gustad, a researcher at the Norwegian University of Science and Technology (NTNU), Nord University, and Levanger Hospital, 250 out of every 100,000 Norwegians develop sepsis for the first time each year. The incidence rates, adjusted for age, remained constant throughout the research period and were found to be higher than previously indicated.

The study was carried out by the research group at NTNU’s Central Norwegian Centre for Sepsis Research and examined data from 2008 through 2021. The findings were published in the British Medical Journal, BMJ Open.

The quality of the data is robust, as the research was conducted using national registry studies, and is the first nationwide sepsis investigation extending over a lengthy timeframe. It includes data from all hospitalized patients, not just those in intensive care. A total of 317,705 hospital admissions for sepsis were recorded during this period, of which 222,832 were first-time sepsis patients.

Mortality rates have declined significantly during this period, dropping by 43 percent for those admitted with sepsis for the first time. Overall, hospital mortality rates declined by one-third, irrespective of whether patients were experiencing sepsis for the first time or had prior episodes.

During the initial two years of the Covid-19 pandemic, a decline in first-time sepsis cases was noted, possibly attributable to social distancing measures. There was also a marked increase in hospital mortality rates from sepsis during the pandemic, particularly in 2021.

The pandemic increased awareness about sepsis, particularly that caused by viral infections. Of the 30,000 people admitted with sepsis in 2020 and 2021, around 10 percent were cases of Covid-19 sepsis, with a higher mortality rate compared to other causes of sepsis.

The study also highlighted an increasing trend in recurrent sepsis, particularly among those above 60 years of age. In individuals older than 80, the rate of recurring sepsis more than quintupled in 2021 compared to 2008.

Contrary to prior professional opinions, the increase in sepsis cases is not attributable to changes in diagnostic coding regulations. The study employed consistent coding throughout the research period, ensuring the validity of the observed changes.

The findings have implications for healthcare professionals, policymakers, and health planning authorities. The research contradicts earlier beliefs about the incidence and nature of sepsis, emphasizing the need for preventive measures, particularly for those who are at risk of recurrent sepsis.

The study received funding from the collaborative body NTNU/Central Norway Health Region and from the Nord-Trøndelag HF Health Authority.

Reference: “Long-term temporal trends in incidence rate and case fatality of sepsis and COVID-19-related sepsis in Norwegian hospitals, 2008–2021: a nationwide registry study” by Nina Vibeche Skei et al., published on 1 August 2023, in BMJ Open. DOI: 10.1136/bmjopen-2023-071846.

Frequently Asked Questions (FAQs) about Sepsis in Norway

What is the main finding of the new study on sepsis in Norway?

The main finding of the study is that sepsis occurs more frequently in Norway than previously estimated, affecting 250 out of every 100,000 Norwegians annually.

Does the study indicate an increase in sepsis cases in Norway?

Yes, the study reveals that sepsis is more prevalent than previously thought. One of the key factors for the increase is the rise in recurring cases of sepsis, especially among the elderly population.

Who conducted this comprehensive study on sepsis in Norway?

The study was led by researchers from the Norwegian University of Science and Technology (NTNU), Nord University, and Levanger Hospital.

How reliable is the data used in the study?

The study is based on a national registry and includes data on 317,705 hospital admissions due to sepsis from 2008 up to and including 2021. The comprehensive nature of the data makes it highly reliable.

Has sepsis-related hospital mortality changed?

Yes, the study shows a significant decline in sepsis-related hospital mortality. Mortality rates in hospitals have dropped by 43 percent for those admitted with sepsis for the first time.

What impact did the Covid-19 pandemic have on sepsis cases?

During the first two years of the Covid-19 pandemic, there was a decrease in hospital admissions with first-time sepsis. The researchers attribute this to social distancing measures. However, sepsis mortality rates in hospitals increased during the pandemic, particularly in 2021.

What are the implications of the study for healthcare policy?

The study underscores the need for healthcare policy planners to focus on the rising incidence of sepsis, particularly recurring cases. Preventive measures targeting this patient group are essential.

Who funded the study?

The study was funded by PhD funds from the collaborative body NTNU/Central Norway Health Region and from the Nord-Trøndelag HF Health Authority.

What is the period of the study?

The study covers a period from 2008 to 2021, making it one of the most comprehensive studies on sepsis trends over a 14-year period.

Where has the study been published?

The study has been published in the British Medical Journal, BMJ Open, and is available for public access.

More about Sepsis in Norway

You may also like

7 comments

Mike O'Brien October 24, 2023 - 2:13 pm

impressive that they’ve managed to reduce the mortality rates so much, but seems like there’s still a lot more to be done.

Reply
Alex Brown October 24, 2023 - 2:29 pm

Health policy planners really need to step up their game now, recurring sepsis looks like a ticking time bomb.

Reply
Karen Williams October 24, 2023 - 3:24 pm

The study’s long period is really impressive. Makes the findings much more reliable in my eyes.

Reply
Sarah Collins October 25, 2023 - 2:06 am

interesting how Covid-19 has made us more aware of sepsis, never really thought the two would be linked.

Reply
Tim Johnson October 25, 2023 - 4:13 am

So social distancing actually reduced sepsis rates? thats a positive side effect I guess.

Reply
Emily Davis October 25, 2023 - 6:36 am

Didn’t know sepsis could come back like that. Especially worrying for the elderly :/

Reply
John Smith October 25, 2023 - 8:11 am

Wow, this is eye-opening! Always thought sepsis was sorta rare but 250 out of every 100,000 people? That’s a lot.

Reply

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

SciTechPost is a web resource dedicated to providing up-to-date information on the fast-paced world of science and technology. Our mission is to make science and technology accessible to everyone through our platform, by bringing together experts, innovators, and academics to share their knowledge and experience.

Subscribe

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!